| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Ordonez Claudia is a Chief Medical Officer at Keros Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $11K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11, 2021 | KROS Keros Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 1,000 | $50.99 | $50,990.09 | -74.2% | -37.5% | -43.2% | |
| May 11, 2021 | KROS Keros Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 1,000 | $50.15 | $50,150.00 | -100% | -31.3% | -17.1% | |
| Apr 12, 2021 | KROS Keros Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 1,000 | $59.93 | $59,926.26 | -54.6% | -28.5% | +6.9% | |
| Mar 11, 2021 | KROS Keros Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 1,000 | $64.56 | $64,555.85 | -62.3% | -19.3% | -18.8% | |
| Feb 11, 2021 | KROS Keros Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 1,000 | $64.84 | $64,841.29 | -37.9% | - | - |